Link Pharma Chem Ltd
Link Pharma Chem Ltd (LINKPH) last traded at ₹28, a market capitalisation of ₹12.4 crore. Over the past 52 weeks the stock has ranged between ₹21 and ₹41.9. Link Pharma Chem Ltd last reported results for the quarter ended Jun 2026, with sales of ₹8.77 crore and net profit of ₹0.32 crore. Figures are as of 25 Aug 2026 and are not real time.
Link Pharma Chem Ltd share price and key metrics
Metrics as of 25 Aug 2026. Not real time.
Link Pharma Chem Ltd quarterly results
In the quarter ended Jun 2026, sales were ₹8.77 cr, up 12.3% from ₹7.81 cr a year earlier. Net profit was ₹0.32 cr, down 20.0% year on year.
| ₹ crore | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Sales | 4.8 | 5.34 | 6.45 | 7.81 | 6.29 | 6.73 | 6.59 | 8.77 |
| Expenses | 5.1 | 5.23 | 6.68 | 7.17 | 5.95 | 6.04 | 6.83 | 8.32 |
| Operating profit | -0.3 | 0.11 | -0.23 | 0.64 | 0.34 | 0.69 | -0.24 | 0.45 |
| OPM % | -6.25% | 2.06% | -3.57% | 8.19% | 5.41% | 10.25% | -3.64% | 5.13% |
| Other income | 0.36 | -0.56 | 0.12 | 0.21 | 0.05 | -0.2 | 0.15 | 0.35 |
| Interest | 0.21 | 0.21 | 0.14 | 0.1 | 0.13 | 0.14 | 0.15 | 0.14 |
| Depreciation | 0.24 | 0.24 | 0.24 | 0.24 | 0.25 | 0.25 | 0.25 | 0.27 |
| Profit before tax | -0.39 | -0.9 | -0.49 | 0.51 | 0.01 | 0.1 | -0.49 | 0.39 |
| Tax % | -20.51% | -24.44% | -26.53% | 21.57% | 0.00% | 40.00% | -16.33% | 17.95% |
| Net profit | -0.31 | -0.67 | -0.35 | 0.4 | 0.02 | 0.07 | -0.41 | 0.32 |
| EPS (₹) | -0.70 | -1.51 | -0.79 | 0.90 | 0.05 | 0.16 | -0.92 | 0.72 |
Consolidated figures as reported by the company. Percentages are as published; totals may not sum exactly.
Link Pharma Chem Ltd annual results
| ₹ crore | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|---|---|---|
| Sales | 34.81 | 53.56 | 38.76 | 29.9 | 25.43 | 27.43 | 28.38 |
| Operating profit | 3.14 | 3.54 | 2.72 | -0.65 | 0.13 | 1.45 | 1.24 |
| OPM % | 9.02% | 6.61% | 7.02% | -2.17% | 0.51% | 5.29% | 4.37% |
| Net profit | 1.08 | 1.88 | 0.65 | -1.36 | -1.03 | 0.08 | 0 |
| EPS (₹) | 2.43 | 4.23 | 1.46 | -3.06 | -2.32 | 0.18 | 0.01 |
TTM is the trailing twelve months to the most recent quarter.
Link Pharma Chem Ltd growth and returns
- 10 Years
- 8%
- 5 Years
- -5%
- 3 Years
- -11%
- TTM
- 16%
- 10 Years
- 7%
- 5 Years
- -42%
- 3 Years
- -48%
- TTM
- 100%
- 10 Years
- 9%
- 5 Years
- -3%
- 3 Years
- -19%
- 1 Year
- -22%
- 10 Years
- 4%
- 5 Years
- -1%
- 3 Years
- -6%
- Last Year
- 1%
Link Pharma Chem Ltd shareholding pattern
Promoters held 52.40% at Jun 2026, up from 51.49% at Jun 2025. DIIs 0.02%.
| % held | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Promoters | 51.49% | 51.49% | 51.49% | 51.49% | 51.49% | 51.49% | 52.40% | 52.40% |
| DIIs | 0.02% | 0.02% | 0.02% | 0.02% | 0.02% | 0.02% | 0.02% | 0.02% |
| Public | 48.49% | 48.50% | 48.49% | 48.50% | 48.49% | 48.49% | 47.59% | 47.58% |
| No. of shareholders | 6,151 | 6,181 | 6,160 | 6,112 | 6,090 | 6,063 | 6,020 | 6,005 |
As disclosed by the company to the exchanges. The last row is a count of shareholders, not a percentage.
Link Pharma Chem Ltd corporate filings
- Re-appointment of Mr. Satish G. Thakur as Whole Time Director for 3 years.Company Updatelow impact
Cruxal's analysis: Link Pharma Chem Ltd. has formally announced the re-appointment of Mr. Satish G. Thakur…
Read the full analysis - Re-appointment of Mr. Rishikesh Thakur as Managing Director of the Company for 3 years.Company Updatelow impact
Cruxal's analysis: Link Pharma Chem Ltd. has formally announced the re-appointment of Mr. Rishikesh Thakur…
Read the full analysis - Voting Results pursuant to clause 44(3) of SEBI LODR Regulations, 2015, and Scrutinizer''s report for 41st Annual General Meeting of the Company.AGM/EGMlow impact
Cruxal's analysis: Link Pharma Chem Limited has successfully concluded its 41st Annual General Meeting held…
Read the full analysis - Summary proceeding of 41st Annual General Meeting of the Company.AGM/EGMlow impact
Cruxal's analysis: Link Pharma Chem Limited has successfully concluded its 41st Annual General Meeting held…
Read the full analysis - Newspaper publication of Unaudited Financial results of the Company for the Quarter ended June 30, 2026 published on 06th August, 2026 in Business Standard (English edition) and Loksatta ....Company Updatehigh impact
Cruxal's analysis: Link Pharma Chem Limited has released its unaudited financial results for the quarter…
Read the full analysis - Outcome of Board Meeting held on 05th August, 2026.Board Meetinghigh impact
Cruxal's analysis: Link Pharma Chem Limited reported a significant financial turnaround for the quarter…
Read the full analysis
This page shows filings on a one-hour delay. Sign in to see them as they land, with Cruxal's analysis of what each one means.
Track Link Pharma Chem Ltd
Cruxal reads every Link Pharma Chem Ltd filing as it lands, scores what it means for the stock, and emails you the ones that matter. Free to start.
Cruxal publishes market data and coverage for information only. Nothing here is investment advice.